Acute Myopericarditis Post-Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Differs From Viral Myocarditis.

Correa, Hernan; Soslow, Jonathan H; Dendy, Jeffrey M; Creech, C Buddy

Correa, Hernan; Soslow, Jonathan H; Dendy, Jeffrey M; Creech, C Buddy.

Affiliation

Correa H; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Soslow JH; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Dendy JM; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Creech CB; Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Clin Infect Dis ; 75(1): e926, 2022 08 24.

Article in En | MEDLINE | ID: mdl-34849644

Subject(s)

COVID-19; Myocarditis; Pericarditis; Virus Diseases; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Injections, Intravenous; Myocarditis/drug therapy; Myocarditis/virology; Pericarditis/drug therapy; Pericarditis/virology; RNA, Messenger/therapeutic use; Vaccines, Synthetic; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pericarditis / Virus Diseases / COVID-19 / Myocarditis Limits: Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google